MBX Biosciences, Inc. (MBX)
(Delayed Data from NSDQ)
$11.13 USD
-0.54 (-4.63%)
Updated Aug 7, 2025 04:00 PM ET
After-Market: $11.13 0.00 (0.00%) 7:18 PM ET
4-Sell of 5 4
D Value F Growth B Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, MBX Biosciences, Inc. has a market cap of $390.06M, which represents its share price of $11.67 multiplied by its outstanding shares number of 33.42M. As a small-cap company, MBX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
MBX 11.13 -0.54(-4.63%)
Will MBX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MBX based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for MBX
MBX Biosciences Q2 GAAP EPS of -$0.58
MBX Biosciences Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights | ...
MBX Biosciences sees cash runway into mid-2027
MBX Biosciences reports Q2 EPS (58c), consensus (76c)
Block downgraded, Wayfair upgraded: Wall Street's top analyst calls